Robbert Bredius
- Naam
- Dr. R.G.M. Bredius
- Telefoon
- +31 71 526 3168
- r.g.m.bredius@lumc.nl
- Faculteit Geneeskunde
- Divisie 3
- Willem-Alexander erziekenhuis
- Moise, K.J.; Oepkes, D.; Lopriore, E. & Bredius, R.G.M. (2022), Targeting neonatal Fc receptor: potential clinical applications in pregnancy, Ultrasound in Obstetrics & Gynecology 60(2): 167-175.
- Oegema, S.; Henriet, S.S.V.; Aerde, K.J. van; Bredius, R.G.M. & Berghuis, D. (2022), First Successful Allogeneic Hematopoietic Stem Cell Transplantation for MKL1 Deficiency.
- Huisman, E.J.; Brooimans, A.R.; Mayer, S.; Joosten, M.; Bont, L. de; Dekker, M.; Rammeloo, E.L.M.; Smiers, F.J.; Hagen, P.M. van; Zwaan, C.M.; Haas, M. de; Cnossen, M.H. & Dalm, V.A.S.H. (2022), Patients with chromosome 11q deletions are characterized by inborn errors of immunity involving both B and T lymphocytes, Journal of Clinical Immunology 42(7): 1521-1534.
- Melsen, J.E.; Ostaijen-Ten Dam, M.M. van; Akker, E.B. van den; Welters, M.J.P.; Heezen, K.C.; Pico-Knijnenburg, I.; Kolijn, P.M.; Bredius, R.G.M.; Doorn, R. van; Langerak, A.W.; Schilham, M.W. & Lankester, A.C. (2022), T and NK cells in IL2RG-deficient patient 50 years after hematopoietic stem cell transplantation, Journal of Clinical Immunology.
- Lankester, A.C.; Neven, B.; Mahlaoui, N.; Asmuth, E.G.J. von; Courteille, V.; Alligon, M.; Albert, M.H.; Serra, I.B.; Bader, P.; Balashov, D.; Beier, R.; Bertrand, Y.; Blanche, S.; Bordon, V.; Bredius, R.G.; Cant, A.; Cavazzana, M.; Diaz-De-Heredia, C.; Dogu, F.; Ehlert, K.; Entz-Werle, N.; Fasth, A.; Ferrua, F.; Ferster, A.; Formankova, R.; Friedrich, W.; Gonzalez-Vicent, M.; Gozdzik, J.; Gungor, T.; Hoenig, M.; Ikinciogullari, A.; Kalwak, K.; Kansoy, S.; Kupesiz, A.; Lanfranchi, A.; Lindemans, C.A.; Meisel, R.; Michel, G.; Miranda, N.A.A.; Moraleda, J.; Moshous, D.; Pichler, H.; Rao, K.; Sedlacek, P.; Slatter, M.; Soncini, E.; Speckmann, C.; Sundin, M.; Toren, A.; Vettenranta, K.; Worth, A.; Yesilipek, M.A.; Zecca, M.; Porta, F.; Schulz, A.; Veys, P.; Fischer, A. & Gennery, A.R. (2022), Hematopoietic cell transplantation in severe combined immunodeficiency: , Journal of Allergy and Clinical Immunology 149(5): 1744-+.
- Bognar, T.; Bartelink, I.H.; Egberts, T.C.G.; Rademaker, C.M.A.; Versluys, A.B.; Slatter, M.A.; Kletzel, M.; Nath, C.E.; Cuvelier, G.D.E.; Savic, R.M.; Dvorak, C.; Long-Boyle, J.R.; Cowan, M.J.; Bittencourt, H.; Bredius, R.G.M.; Gungor, T.; Shaw, P.J.; Ansari, M.; Hassan, M.; Krajinovic, M.; Hempel, G.; Marktel, S.; Chiesa, R.; Theoret, Y.; Lund, T.; Orchard, P.J.; Wynn, R.F.; Boelens, J.J. & Lalmohamed, A. (2022), Association between the magnitude of intravenous busulfan exposure and development of hepatic veno-occlusive disease in children and young adults undergoing myeloablative allogeneic hematopoietic cell transplantation, Transplantation and Cellular Therapy 28(4): 196-202.
- Stoep, M.Y.E.C. van der; Oostenbrink, L.V.E.; Bredius, R.G.M.; Moes, D.J.A.R.; Guchelaar, H.J.; Zwaveling, J. & Lankester, A.C. (2022), Therapeutic Drug Monitoring of Conditioning Agents in Pediatric Allogeneic Stem Cell Transplantation; Where do We Stand?, Frontiers in Pharmacology 13.
- Stoep, M.Y.E.C. van der; Bertaina, A.; Moes, D.J.A.R.; Algeri, M.; Bredius, R.G.M.; Smiers, F.J.W.; Berghuis, D.; Buddingh, E.P.; Mohseny, A.B.; Guchelaar, H.J.; Locatelli, F.; Zwaveling, J. & Lankester, A.C. (2022), Impact of treosulfan exposure on early and long-term clinical outcomes in pediatric allogeneic hematopoietic stem cell transplantation recipients, Transplantation and Cellular Therapy 28(2).
- Admiraal, R.; Nierkens, S.; Bierings, M.B.; Bredius, R.G.M.; Vliet, I. van; Jiang, Y.L.; Lopez-Yurda, M.; Versluijs, A.B.; Zwaan, C.M.; Lindemans, C.A. & Boelens, J.J. (2022), Individualised dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (PARACHUTE), The Lancet Haematology 9(2): E111-E120.
- Damoiseaux, M.; Damoiseaux, J.; Pico-Knijnenburg, I.; Burg, M. van der; Bredius, R. & Well, G. van (2022), Lessons learned from the diagnostic work-up of a patient with the bare lymphocyte syndrome type II, Clinical Immunology 235.
- Uppugunduri, C.R.S.; Curtis, P.H.D.; Nava, T.; Rezgui, M.A.; Mlakar, V.; Mlakar, S.J.; Waespe, N.; Theoret, Y.; Gumy-Pause, F.; Bernard, F.; Chalandon, Y.; Boelens, J.J.; Bredius, R.G.M.; Dalle, J.H.; Nath, C.; Corbacioglu, S.; Peters, C.; Bader, P.; Shaw, P.; Bittencourt, H.; Krajinovic, M. & Ansari, M. (2022), Association study of candidate DNA-repair gene variants and acute graft versus host disease in pediatric patients receiving allogeneic hematopoietic stem-cell transplantation, Pharmacogenomics Journal 22(1): 9-18.
- Blom, M.; Pico-Knijnenburg, I.; Montfrans, J.M. van; Bredius, R.G.M.; Burg, M. van der; Swen, J.J. & Berghuis, D. (2021), Abnormal Results of Newborn Screening for SCID After Azathioprine Exposure In Utero: Benefit of TPMT Genotyping in Both Mother and Child, Journal of Clinical Immunology.
- Stoep, M.Y.E.C. van der; Berghuis, D.; Bredius, R.G.M.; Buddingh, E.P.; Mohseny, A.B.; Smiers, F.J.W.; Guchelaar, H.J.; Lankester, A.C. & Zwaveling, J. (2021), Treosulfan-induced myalgia in pediatric hematopoietic stem cell transplantation identified by an electronic health record text mining tool, Scientific Reports 11(1).
- Mlakar, S.J.; Satyanarayana, C.R.U.; Nava, T.; Mlakar, V.; Golay, H.; Robin, S.; Waespe, N.; Rezgui, M.A.; Chalandon, Y.; Boelens, J.J.; Bredius, R.G.M.; Dalle, J.H.; Peters, C.; Corbacioglu, S.; Bittencourt, H.; Krajinovic, M.; Ansari, M. & European Soc Blood Marrow Transpla (2021), GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation, Journal of Cancer Research and Clinical Oncology 148.
- Marle, M.E.V.; Blom, M.; Burg, M. van der; Bredius, R.G.M. & Ploeg, C.P.B. van der (2021), Economic evaluation of different screening strategies for severe combined immunodeficiency based on real-life data, International Journal of Neonatal Screening 7(3).
- Hassine, K. ben; Nava, T.; Thoret, Y.; Nath, C.E.; Daali, Y.; Kassir, N.; Lewis, V.; Bredius, R.G.M.; Shaw, P.J.; Bittencourt, H.; Krajinovic, M.; Uppugunduri, C.R.S. & Ansari, M. (2021), Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation, CPT: Pharmacometrics and Systems Pharmacology 10(9): 1043-1056.
- Blom, M.; Pico-Knijnenburg, I.; Imholz, S.; Vissers, L.; Schulze, J.; Werner, J.; Bredius, R. & Burg, M. van der (2021), Second tier testing to reduce the number of non-actionable secondary findings and false-positive referrals in newborn screening for severe combined immunodeficiency, Journal of Clinical Immunology 41.
- Hashem, H.; Bucciol, G.; Ozen, S.; Unal, S.; Bozkaya, I.O.; Akarsu, N.; Taskinen, M.; Koskenvuo, M.; Saarela, J.; Dimitrova, D.; Hickstein, D.D.; Hsu, A.P.; Holland, S.M.; Krance, R.; Sasa, G.; Kumar, A.R.; Muller, I.; Sousa, M.A. de; Delafontaine, S.; Moens, L.; Babor, F.; Barzaghi, F.; Cicalese, M.P.; Bredius, R.; Montfrans, J. van; Baretta, V.; Cesaro, S.; Stepensky, P.; Benedicte, N.; Moshous, D.; Guenno, G. le; Boutboul, D.; Dalal, J.; Brooks, J.P.; Dokmeci, E.; Dara, J.; Lucas, C.L.; Hambleton, S.; Wilson, K.; Jolles, S.; Koc, Y.; Gungor, T.; Schnider, C.; Candotti, F.; Steinmann, S.; Schulz, A.; Chambers, C.; Hershfield, M.; Ombrello, A.; Kanakry, J.A. & Meyts, I. (2021), Hematopoietic cell transplantation cures adenosine deaminase 2 deficiency, Journal of Clinical Immunology 41(7): 1633-1647.
- Ansari, M.; Petrykey, K.; Rezgui, M.A.; Vecchio, V. del; Cortyl, J.; Ameur, M.; Nava, T.; Beaulieu, P.; St-Onge, P.; Mlakar, S.J.; Uppugunduri, C.R.S.; Theoret, Y.; Bartelink, I.H.; Boelens, J.J.; Bredius, R.G.M.; Dalle, J.H.; Lewis, V.; Kangarloo, B.S.; Corbacioglu, S.; Sinnett, D.; Bittencourt, H. & Krajinovic, M. (2021), Genetic susceptibility to acute graft versus host disease in pediatric patients undergoing HSCT, Bone Marrow Transplantation.
- Kielsen, K.; Oostenbrink, L.V.E.; Asmuth, E.G.J. von; Jansen-Hoogendijk, A.M.; Ostaijen-ten Dam, M.M. van; Ifversen, M.; Heilmann, C.; Schilham, M.W.; Halteren, A.G.S. van; Bredius, R.G.M.; Lankester, A.C.; Jol-van Der Zijde, C.M.; Tol, M.J.D. van & Muller, K. (2021), IL-7 and IL-15 Levels Reflect the Degree of T Cell Depletion during Lymphopenia and Are Associated with an Expansion of Effector Memory T Cells after Pediatric Hematopoietic Stem Cell Transplantation, Journal of Immunology 206(12): 2828-2838.
- Oostenbrink, L.V.E.; Pool, E.S.; Jol-van der Zijde, C.M.; Jansen-Hoogendijk, A.M.; Vervat, C.; Halteren, A.G.S. van; Bredius, R.G.M.; Smiers, F.J.W.; Tol, M.J.D. van; Schilham, M.W.; Lankester, A.C. & Mohseny, A.B. (2021), Successful mismatched hematopoietic stem cell transplantation for pediatric hemoglobinopathy by using ATG and post-transplant cyclophosphamide, Bone Marrow Transplantation.
- Jansen, S.J.; Lopriore, E.; Bredius, R.G.M.; Beek, M.T. van der; Moes, D.J.A.R. & Bekker, V. (2021), Benzylpenicillin Serum Concentrations in Neonates With Group B Streptococci Sepsis or Meningitis A Descriptive Cohort Study, The Pediatric Infectious Disease Journal 40(5): 434-439.
- Bakhtiar, S.; Salzmann-Manrique, E.; Blok, H.J.; Eikema, D.J.; Hazelaar, S.; Ayas, M.; Toren, A.; Goldstein, G.; Moshous, D.; Locatelli, F.; Merli, P.; Michel, G.; Ozturk, G.; Schulz, A.; Heilmann, C.; Ifversen, M.; Wynn, R.F.; Aleinikova, O.; Bertrand, Y.; Tbakhi, A.; Veys, P.; Karakukcu, M.; Kupesiz, A.; Ghavamzadeh, A.; Handgretinger, R.; Unal, E.; Perez-Martinez, A.; Gokce, M.; Porta, F.; Aksu, T.; Karasu, G.; Badell, I.; Ljungman, P.; Skorobogatova, E.; Yesilipek, A.; Zuckerman, T.; Bredius, R.R.G.; Stepensky, P.; Shadur, B.; Slatter, M.; Gennery, A.R.; Albert, M.H.; Bader, P.; Lankester, A.; Pediat Dis Working Party & Inborn Errors Working Party EBMT (2021), Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III, Blood Advances 5(1): 262-273.
- Smits, B.M.; Budde, I.K.; Vries, E. de; Berge, I.J.M. ten; Bredius, R.G.M.; Deuren, M. van; Dissel, J.T. van; Ellerbroek, P.M.; Flier, M. van der; Hagen, P.M. van; Nieuwhof, C.; Rutgers, B.; Sanders, L.E.A.M.; Simon, A.; Kuijpers, T.W. & Montfrans, J.M. van (2020), Immunoglobulin replacement therapy versus antibiotic prophylaxis as treatment for incomplete primary antibody deficiency, Journal of Clinical Immunology 41.
- Lum, S.H.; Elfeky, R.; Achini, F.R.; Margarit-Soler, A.; Cinicola, B.; Perez-Heras, I.; Nademi, Z.; Flood, T.; Cheetham, T.; Worth, A.; Qasim, W.; Amin, R.; Rao, K.; Chiesa, R.; Bredius, R.G.M.; Amrolia, P.; Abinun, M.; Hambleton, S.; Veys, P.; Gennery, A.R.; Lankester, A. & Slatter, M. (2021), Outcome of Non-hematological Autoimmunity After Hematopoietic Cell Transplantation in Children with Primary Immunodeficiency, Journal of Clinical Immunology 41(1): 171-184.
- Blom, M.; Bredius, R.G.M.; Jansen, M.E.; Weijman, G.; Kemper, E.A.; Vermont, C.L.; Hollink, I.H.I.M.; Dik, W.A.; Montfrans, J.M. van; Gijn, M.E. van; Henriet, S.S.; Aerde, K.J. van; Koole, W.; Lankester, A.C.; Dekkers, E.H.B.M.; Schielen, P.C.J.I.; Vries, M.C. de; Henneman, L.; Burg, M. van der & SONNET-Study Grp (2021), Parents' perspectives and societal acceptance of implementation of newborn screening for SCID in the Netherlands, Journal of Clinical Immunology 41(1): 99-108.
- Schauwvlieghe, A.F.A.D.; Bredius, R.G.M.; Verdijk, R.M.; Smiers, F.J.W.; Beek, M.T. van der; Goemans, B.F.; Zwaan, C.M.; Bruggemann, R.J. & Rijnders, B.J.A. (2020), Management of cerebral azole-resistant Aspergillus fumigatus infection, Journal of Global Antimicrobial Resistance 22: 354-357.
- Ansari, M.; Petrykey, K.; Rezgui, M.A.; Vecchio, V. del; Cortyl, J.; Ralph, R.O.; Nava, T.; Beaulieu, P.; St-Onge, P.; Mlakar, S.J.; Curtis, P.H.D.; Uppugunduri, C.R.S.; Lesne, L.; Theoret, Y.; Chalandon, Y.; Bartelink, I.H.; Boelens, J.J.; Bredius, R.G.M.; Dalle, J.H.; Lewis, V.; Kangarloo, B.S.; Peters, C.; Sinnett, D.; Bittencourt, H.; Krajinovic, M. & Pediat Dis Working Party European (2020), Genetic susceptibility to hepatic sinusoidal obstruction syndrome in pediatric patients undergoing hematopoietic stem cell transplantation, Biology of Blood and Marrow Transplantation 26(5): 920-927.
- Achini, F.R.; Smiers, F.; Zwaginga, J.J.; Tol, M.J.D. van; Jol-van der Zijde, C.M.; Schilham, M.W.; Lankester, A.C. & Bredius, R.G.M. (2020), Plasmapheresis to eliminate immunosuppressive alemtuzumab levels in a child with disseminated adenovirus infection after allogeneic stem cell transplantation.
- Ammann, S.; Fuchs, S.; Martin-Martin, L.; Castro, C.N.; Spielberger, B.; Klemann, C.; Elling, R.; Heeg, M.; Speckmann, C.; Hainmann, I.; Kaiser-Labusch, P.; Horneff, G.; Thalhammer, J.; Bredius, R.G.; Stadt, U. zur; Lehmberg, K.; Fuchs, I.; Spee-Mayer, C. von; Henneke, P. & Ehl, S. (2020), Functional flow cytometry of monocytes for routine diagnosis of innate primary immunodeficiencies.
- Admiraal, R.; Jol-van der Zijde, C.M.; Silva, J.M.F.; Knibbe, C.A.J.; Lankester, A.C.; Boelens, J.J.; Hale, G.; Etuk, A.; Wilson, M.; Adams, S.; Veys, P.; Kesteren, C. van & Bredius, R.G.M. (2019), Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome, Clinical Pharmacokinetics 58(12): 1609-1620.
- Solms, L.; Vianen, A.E.M. van; Theeboom, T.; Koen, J.; Pagter, A.P.J. de; Hoog, M. de; Rossum, A.M.C. van; Kollen, W.J.W.; Bredius, R.G.M.; Heesterman, A.J.; Houten, M.A. van; Walenkamp, M.J.E.; Zandbergen, A.A.M.; Schuit, S.C.E.; Bromberg, J.E.C.; Willemse, A.; Hee, S.M. van den; Heuvel, M. van den; Bakker-Pieper, A. & Challenge Support Res Network (2019), Keep the fire burning: a survey study on the role of personal resources for work engagement and burnout in medical residents and specialists in the Netherlands, BMJ Open 9(11).
- Farmer, J.R.; Foldvari, Z.; Ujhazi, B.; Ravin, S.S. de; Chen, K.; Bleesing, J.J.H.; Schuetz, C.; Al-Herz, W.; Abraham, R.S.; Joshi, A.Y.; Costa-Carvalho, B.T.; Buchbinder, D.; Booth, C.; Reiff, A.; Ferguson, P.J.; Aghamohammadi, A.; Abolhassani, H.; Puck, J.M.; Adeli, M.; Cancrini, C.; Palma, P.; Bertaina, A.; Locatelli, F.; Matteo, G. di; Geha, R.S.; Kanariou, M.G.; Lycopoulou, L.; Tzanoudaki, M.; Sleasman, J.W.; Parikh, S.; Pinero, G.; Fischer, B.M.; Dbaibo, G.; Unal, E.; Patiroglu, T.; Karakukcu, M.; Al-Saad, K.K.; Dilley, M.A.; Pai, S.Y.; Dutmer, C.M.; Gelfand, E.W.; Geier, C.B.; Eibl, M.M.; Wolf, H.M.; Henderson, L.A.; Hazen, M.M.; Bonfim, C.; Wolska-Kusnierz, B.; Butte, M.J.; Hernandez, J.D.; Nicholas, S.K.; Stepensky, P.; Chandrakasan, S.; Miano, M.; Westermann-Clark, E.; Goda, V.; Krivan, G.; Holland, S.M.; Fadugba, O.; Henrickson, S.E.; Ozen, A.; Karakoc-Aydiner, E.; Baris, S.; Kiykim, A.; Bredius, R.; Hoeger, B.; Boztug, K.; Pashchenko, O.; Neven, B.; Moshous, D.; Villartay, J.P. de; Bousfiha, A.A.; Hill, H.R.; Notarangelo, L.D. & Walter, J.E. (2019), Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency, Journal of Allergy and Clinical Immunology: In Practice 7(6): 1970-+.
- Bekker, V.; Zwittink, R.D.; Knetsch, C.W.; Sanders, I.M.J.G.; Berghuis, D.; Heidt, P.J.; Vossen, J.M.J.J.; Vos, W.M. de; Belzer, C.; Bredius, R.G.M.; van't Hof, P.J.; Lankester, A.C. & Kuijper, E.J. (2019), Dynamics of the Gut Microbiota in Children Receiving Selective or Total Gut Decontamination Treatment during Hematopoietic Stem Cell Transplantation, Biology of Blood and Marrow Transplantation 25(6): 1164-1171.
- Ferrua, F.; Galimberti, S.; Courteille, V.; Slatter, M.A.; Booth, C.; Moshous, D.; Neven, B.; Blanche, S.; Cavazzana, M.; Laberko, A.; Shcherbina, A.; Balashov, D.; Soncini, E.; Porta, F.; Al-Mousa, H.; Al-Saud, B.; Al-Dhekri, H.; Arnaout, R.; Formankova, R.; Bertrand, Y.; Lange, A.; Smart, J.; Wolska-Kusnierz, B.; Aquino, V.M.; Dvorak, C.C.; Fasth, A.; Fouyssac, F.; Heilmann, C.; Hoenig, M.; Schuetz, C.; Kelecic, J.; Bredius, R.G.M.; Lankester, A.C.; Lindemans, C.A.; Suarez, F.; Sullivan, K.E.; Albert, M.H.; Kalwak, K.; Barlogis, V.; Bhatia, M.; Bordon, V.; Czogala, W.; Alonso, L.; Dogu, F.; Gozdzik, J.; Ikinciogullari, A.; Krivan, G.; Ljungman, P.; Meyts, I.; Mustillo, P.; Smith, A.R.; Speckmann, C.; Sundin, M.; Keogh, S.J.; Shaw, P.J.; Boelens, J.J.; Schulz, A.S.; Sedlacek, P.; Veys, P.; Mahlaoui, N.; Janda, A.; Davies, E.G.; Fischer, A.; Cowan, M.J.; Gennery, A.R.; SCETIDE; PIDTC; EBMT & ESID IEWP (2019), Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study, Journal of Allergy and Clinical Immunology 143(6): 2238-2253.
- Ploeg, C.P.B. van der; Blom, M.; Bredius, R.G.M.; Burg, M. van der; Schielen, P.C.J.I.; Verkerk, P.H. & Akker-van Marle, M.E. van den (2019), Cost-effectiveness of newborn screening for severe combined immunodeficiency, European Journal of Pediatrics 178(5): 721-729.
- Poelman, E.; Hoogeveen-Westerveld, M.; Hout, J.M.P. van den; Bredius, R.G.M.; Lankester, A.C.; Driessen, G.J.A.; Kamphuis, S.S.M.; Pijnappel, W.W.M. & Ploeg, A.T. van der (2019), Effects of immunomodulation in classic infantile Pompe patients with high antibody titers, Orphanet Journal of Rare Diseases 14.
- Oostenbrink, L.V.E.; Jol-van der Zijde, C.M.; Kielsen, K.; Jansen-Hoogendijk, A.M.; Ifversen, M.; Muller, K.G.; Lankester, A.C.; Halteren, A.G.S. van; Bredius, R.G.M.; Schilham, M.W. & Tol, M.J.D. van (2019), Differential Elimination of Anti-Thymocyte Globulin of Fresenius and Genzyme Impacts T-Cell Reconstitution After Hematopoietic Stem Cell Transplantation, Frontiers in Immunology 10.
- Aydin, S.E.; Freeman, A.F.; Al-Herz, W.; Al-Mousa, H.A.; Arnaout, R.K.; Aydin, R.C.; Barlogis, V.; Belohradsky, B.H.; Bonfim, C.; Bredius, R.G.; Chu, J.I.; Ciocarlie, O.C.; Dogu, F.; Gaspar, H.B.; Geha, R.S.; Gennery, A.R.; Hauck, F.; Hawwari, A.; Hickstein, D.D.; Hoenig, M.; Ikinciogullari, A.; Klein, C.; Kumar, A.; Ifversen, M.R.S.; Matthes, S.; Metin, A.; Neven, B.; Pai, S.Y.; Parikh, S.H.; Picard, C.; Renner, E.D.; Sanal, O.; Schulz, A.S.; Schuster, F.; Shah, N.N.; Shereck, E.B.; Slatter, M.A.; Su, H.C.; Montfrans, J. van; Woessmann, W.; Ziegler, J.B.; Albert, M.H.; Inborn Errors Working Party Europe & European Soc Primary Immunodefici (2019), Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 Deficiency, Journal of Allergy and Clinical Immunology: In Practice 7(3): 848-855.
- Jacobse, J.; Mensink, H.; Stoep-Yap, M.Y.E.C. van der; Kollen, W.J.W.; Bresters, D. & Bredius, R.G.M. (2018), Long-term aprepitant for nausea and vomiting associated with gastroparesis in hematopoietic stem cell transplantation, Bone Marrow Transplantation 53(10): 1372-1374.
- Kruizinga, M.D.; Tol, M.J.D. van; Bekker, V.; Netelenbos, T.; Smiers, F.J.; Bresters, D.; Jansen-Hoogendijk, A.M.; Ostaijen-ten Dam, M.M. van; Kollen, W.J.W.; Zwaginga, J.J.; Lankester, A.C. & Bredius, R.G.M. (2018), Risk Factors, Treatment, and Immune Dysregulation in Autoimmune Cytopenia after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients, Biology of Blood and Marrow Transplantation 24(4): 772-778.
- Barzaghi, F.; Hernandez, L.C.A.; Neven, B.; Ricci, S.; Kucuk, Z.Y.; Bleesing, J.J.; Nademi, Z.; Slatter, M.A.; Ulloa, E.R.; Shcherbina, A.; Roppelt, A.; Worth, A.; Silva, J.; Aiuti, A.; Murguia-Favela, L.; Speckmann, C.; Carneiro-Sampaio, M.; Fernandes, J.F.; Baris, S.; Ozen, A.; Karakoc-Aydiner, E.; Kiykim, A.; Schulz, A.; Steinmann, S.; Notarangelo, L.D.; Gambineri, E.; Lionetti, P.; Shearer, W.T.; Forbes, L.R.; Martinez, C.; Moshous, D.; Blanche, S.; Fisher, A.; Ruemmele, F.M.; Tissandier, C.; Ouachee-Chardin, M.; Rieux-Laucat, F.; Cavazzana, M.; Qasim, W.; Lucarelli, B.; Albert, M.H.; Kobayashi, I.; Alonso, L.; Heredia, C.D. de; Kanegane, H.; Lawitschka, A.; Seo, J.J.; Gonzalez-Vicent, M.; Diaz, M.A.; Goyal, R.K.; Sauer, M.G.; Yesilipek, A.; Kim, M.; Yilmaz-Demirdag, Y.; Bhatia, M.; Khlevner, J.; Padilla, E.J.R.; Martino, S.; Montin, D.; Neth, O.; Molinos-Quintana, A.; Valverde-Fernandez, J.; Broides, A.; Pinsk, V.; Ballauf, A.; Haerynck, F.; Bordon, V.; Dhooge, C.; Garcia-Lloret, M.L.; Bredius, R.G.; Kawak, K.; Haddad, E.; Seidel, M.G.; Duckers, G.; Pai, S.Y.; Dvorak, C.C.; Ehl, S.; Locatelli, F.; Goldman, F.; Gennery, A.R.; Cowan, M.J.; Roncarolo, M.G.; Bacchetta, R.; PIDTC; IEWP & European Soc Blood Marrow (2018), Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study, Journal of Allergy and Clinical Immunology 141(3): 1036-+.
- Stoep, M.Y.E.C. van der; Bertaina, A.; Brink, M.H. ten; Bredius, R.G.; Smiers, F.J.; Wanders, D.C.M.; Moes, D.J.A.R.; Locatelli, F.; Guchelaar, H.J.; Zwaveling, J. & Lankester, A.C. (2017), High interpatient variability of treosulfan exposure is associated with early toxicity in paediatric HSCT: a prospective multicentre study, British Journal of Haematology 179(5): 772-780.
- Hashem, H.; Kumar, A.R.; Muller, I.; Babor, F.; Bredius, R.; Dalal, J.; Hsu, A.P.; Holland, S.M.; Hickstein, D.D.; Jolles, S.; Krance, R.; Sasa, G.; Taskinen, M.; Koskenvuo, M.; Saarela, J.; Montfrans, J. van; Wilson, K.; Bosch, B.; Moens, L.; Hershfield, M.; Meyts, I. & Deficiency Adenosine Deaminase (2017), Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2, Blood 130(24): 2682-2688.
- Ansari, M.; Curtis, P.H.D.; Uppugunduri, C.R.S.; Rezgui, M.A.; Nava, T.; Mlakar, V.; Lesne, L.; Theoret, Y.; Chalandon, Y.; Dupuis, L.L.; Schechter, T.; Bartelink, I.H.; Boelens, J.J.; Bredius, R.; Dalle, J.H.; Azarnoush, S.; Sedlacek, P.; Lewis, V.; Champagne, M.; Peters, C.; Bittencourt, H. & Krajinovic, M. (2017), GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study, Oncotarget 8(53): 90852-90867.
- Kruizinga, M.D.; Bresters, D.; Smiers, F.J.; Lankester, A.C. & Bredius, R.G.M. (2017), The use of intravenous pentamidine for the prophylaxis of Pneumocystis pneumonia in pediatric patients, Pediatric Blood and Cancer 64(8).
- Blom, M.; Pico-Knijnenburg, I.; Sijne-van Veen, M.; Boelen, A.; Bredius, R.G.M.; Burg, M. van der & Schielen, P.C.J.I. (2017), An evaluation of the TREC assay with regard to the integration of SCID screening into the Dutch newborn screening program, Clinical Immunology 180: 106-110.
- Admiraal, R.; Nierkens, S.; Witte, M.A. de; Petersen, E.J.; Fleurke, G.J.; Verrest, L.; Belitser, S.V.; Bredius, R.G.M.; Raymakers, R.A.P.; Knibbe, C.A.J.; Minnema, M.C.; Kesteren, C. van; Kuball, J. & Boelens, J.J. (2017), Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis, Lancet Haematology 4(4): E183-E191.
- Kumar, A.R.; Hickstein, D.D.; Ghadir, S.S.; Bertuch, A.A.; Krance, R.A.; Hsu, A.P.; Hashem, H.; Babor, F.; Meisel, R.; Koskenvuo, M.; Taskinen, M.; Seppanen, M.; Borkhardt, A.; Ehl, S.; Jordan, M.B.; Chambers, E.; Kastner, D.; Torgerson, T.R.; Holland, S.M.; Dalal, J.; Bredius, R.G.; Montfrans, J. van; Moens, L.; Hershfield, M.; Meyts, I. & Bosch, B. (2017), HEMATOPOIETIC STEM CELL TRANSPLANTATION RESCUES THE VASCULAR, HAEMATOLOGICAL AND IMMUNOLOGICAL PHENOTYPE IN ADENOSINE DEAMINASE 2 DEFICIENCY, Journal of Clinical Immunology 37(2): 247-248.
- Bank, J.R.; Heidt, S.; Moes, D.J.A.R.; Roelen, D.L.; Mallat, M.J.K.; Boog, P.J.M. van der; Vergunst, M.; Jol-van der Zijde, C.M.; Bredius, R.G.M.; Braat, A.E.; Ringers, J.; Tol, M.J.D. van; Claas, F.H.J.; Reinders, M.E.J. & Fijter, J.W. de (2017), Alemtuzumab Induction and Delayed Acute Rejection in Steroid-Free Simultaneous Pancreas-Kidney Transplant Recipients, Transplantation Direct 3(1).
- Bartelink, I.H.; Lalmohamed, A.; Reij, E.M.L. van; Dvorak, C.C.; Savic, R.M.; Zwaveling, J.; Bredius, R.G.M.; Egberts, A.C.G.; Bierings, M.; Kletzel, M.; Shaw, P.J.; Nath, C.E.; Hempel, G.; Ansari, M.; Krajinovic, M.; Theoret, Y.; Duval, M.; Keizer, R.J.; Bittencourt, H.; Hassan, M.; Gungor, T.; Wynn, R.F.; Veys, P.; Cuvelier, G.D.E.; Marktel, S.; Chiesa, R.; Cowan, M.J.; Slatter, M.A.; Stricherz, M.K.; Jennissen, C.; Long-Boyle, J.R. & Boelens, J.J. (2016), Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis, Lancet Haematology 3(11): E526-E536.
- Cicalese, M.P.; Ferrua, F.; Castagnaro, L.; Pajno, R.; Barzaghi, F.; Giannelli, S.; Dionisio, F.; Brigida, I.; Bonopane, M.; Casiraghi, M.; Tabucchi, A.; Carlucci, F.; Grunebaum, E.; Adeli, M.; Bredius, R.G.; Puck, J.M.; Stepensky, P.; Tezcan, I.; Rolfe, K.; Boever, E. de; Reinhardt, R.R.; Appleby, J.; Ciceri, F.; Roncarolo, M.G. & Aiuti, A. (2016), Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency, Blood 128(1): 45-54.
- Bank, J.; Mallat, M.; Zijde, C.J.V.D.; Bredius, R.; Boog, P. van der; Braat, A.; Ringers, J.; Reinders, M. & Fijter, J. de (2016), Plasma Alemtuzumab Levels Show Great Interpatient Variability, but Are Not Associated with Late Acute Rejection in Simultaneous Pancreas-Kidney Recipients., American Journal of Transplantation 16: 424-425.
- Montfrans, J.M. van; Hartman, E.A.R.; Braun, K.P.J.; Hennekam, E.A.M.; Hak, E.A.; Nederkoorn, P.J.; Westendorp, W.F.; Bredius, R.G.M.; Kollen, W.J.W.; Scholvinck, E.H.; Legger, G.E.; Meyts, I.; Liston, A.; Lichtenbelt, K.D.; Giltay, J.C.; Haaften, G. van; Simons, G.M.D.; Leavis, H.; Sanders, C.J.G.; Bierings, M.B.; Nierkens, S. & Gijn, M.E. van (2016), Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations, Rheumatology 55(5): 902-910.
- , I.C. de vor; Meulen, P.M. van der; Bekker, V.; Verhard, E.M.; Breuning, M.H.; Harnisch, E.; Tol, M.J.D. van; Wieringa, J.W.; Vosse, E. van de & Bredius, R.G.M. (2016), Deletion of the entire interferon-gamma receptor 1 gene causing complete deficiency in three related patients, Journal of Clinical Immunology 36(3): 195-203.
- Wiekmeijer, A.S.; Pike-Overzet, K.; IJspeert, H.; Brugman, M.H.; Wolvers-Tettero, I.L.M.; Lankester, A.C.; Bredius, R.G.M.; Dongen, J.J.M. van; Fibbe, W.E.; Langerak, A.W.; Burg, M. van der & Staal, F.J.T. (2016), Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells, Journal of Allergy and Clinical Immunology 137(2): 517-+.
- Verhoeven, D.H.J.; Claas, E.C.J.; Jol-van der Zijde, C.M.; Thijssen, J.C.P.; Lankester, A.C.; Bredius, R.G.M.; Putter, H.; Kroes, A.C.M.; Egeler, R.M.; Schilham, M.W. & Tol, M.J.D. van (2015), Reactivation of Human Herpes Virus-6 After Pediatric Stem Cell Transplantation Risk Factors, Onset, Clinical Symptoms and Association With Severity of Acute Graft-Versus-Host Disease, Pediatric Infectious Disease Journal 34(10): 1118-1127.
- Pike-Overzet, K.; Wiekmeijer, A.S.; Brugman, M.H.; Wolvers-Tettero, I.L.; Lankester, A.C.; Bredius, R.G.; Dongen, J.J. van; Fibbe, W.E.; Langerak, A.W.; Burg, M. van der & Staal, F.J. (2015), Transplantation of human SCID stem cells in NSG mice gives new insights into human T-cell development, Human Gene Therapy 26(10): A59-A59.
- Pagter, A.P.J. de; Bredius, R.G.M.; Kuijpers, T.W.; Tramper, J.; Burg, M. van der; Montfrans, J. van; Driessen, G.J. & Dutch Working Party Immunodeficien (2015), Overview of 15-year severe combined immunodeficiency in the Netherlands: towards newborn blood spot screening, European Journal of Pediatrics 174(9): 1183-1188.
- Counsilman, C.E.; Jol-van der Zijde, C.M.; Stevens, J.; Cransberg, K.; Bredius, R.G.M. & Sukhai, R.N. (2015), Pharmacokinetics of rituximab in a pediatric patient with therapy-resistant nephrotic syndrome, Pediatric Nephrology 30(8): 1367-1370.
- Admiraal, R.; Kesteren, C. van; Jol-van der Zijde, C.M.; Lankester, A.C.; Bierings, M.B.; Egberts, T.C.G.; Tol, M.J.D. van; Knibbe, C.A.J.; Bredius, R.G.M. & Boelens, J.J. (2015), Association between anti-thymocyte globulin exposure and CD4(+) immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis, Lancet Haematology 2(5): E194-E203.
- Pike-Overzet, K.; Baert, M.R.M.; Schambach, A.; Rothe, M.; Zhang, F.; Lankester, A.C.; Bredius, R.G.M.; Thrasher, A.; Gaspar, B. & Staal, F.J.T. (2015), Successful Correction of Rag1 Severe Combined Immunedefciency at Clinically Relevant Vector Copy Numbers, Molecular Therapy 23: S111-S111.
- Admiraal, R.; Kesteren, C. van; Jol-van der Zijde, C.M.; Tol, M.J.D. van; Bartelink, I.H.; Bredius, R.G.M.; Boelens, J.J. & Knibbe, C.A.J. (2015), Population Pharmacokinetic Modeling of Thymoglobulin (R) in Children Receiving Allogeneic-Hematopoietic Cell Transplantation: Towards Improved Survival Through Individualized Dosing, Clinical Pharmacokinetics 54(4): 435-446.
- Lankester, A.; Bredius, R.; Mahlaoui, N.; Courteille, V.; Provot, J.; Honig, M.; Schulz, A.; Slatter, M.; Gaspar, B.; Veys, P.; Moshous, D.; Neven, B.; Blanche, S.; Cavazzana-Calvo, M.; Fischer, A.; Gennery, A.; EBMT IEWP & EBMT IEWP (2015), Hematopoietic stem cell transplantation between 1968 and 2013 for Severe Combined Immune Deficiency (SCID) below age two: an update by the European Registry (SCETIDE), Bone Marrow Transplantation 50: S105-S106.
- Mahlaoui, N.; Bredius, R.; Lankester, A.; Courteille, V.; Provot, J.; Honig, M.; Schulz, A.; Slatter, M.; Gaspar, B.; Veys, P.; Moshous, D.; Neven, B.; Blanche, S.; Fischer, A.; Gennery, A.; EBMT IEWP & EBMT IEWP (2015), Hematopoietic Stem Cell Transplantation For Patients With Primary Immune Deficiencies In Europe: An Update By The European Registry (SCETIDE), Bone Marrow Transplantation 50: S106-S107.
- Willemsen, L.; Jol-van der Zijde, C.M.; Admiraal, R.; Putter, H.; Jansen-Hoogendijk, A.M.; Ostaijen-ten Dam, M.M.; Wijnen, J.T.; Kesteren, C. van; Waaijer, J.L.M.; Lankester, A.C.; Bredius, R.G.M. & Tol, M.J.D. van (2015), Impact of Serotherapy on Immune Reconstitution and Survival Outcomes After Stem Cell Transplantations in Children: Thymoglobulin Versus Alemtuzumab, Biology of Blood and Marrow Transplantation 21(3): 473-482.
- Lugthart, G.; Jol-van der Zijde, C.M.; Halteren, A.G. van; Bredius, R.G.; Tol, M.J. van; Schilham, M.W. & Lankester, A.C. (2015), Methotrexate prophylaxis prevents severe aGvHD after HLA-identical sibling transplantation for pediatric ALL without compromising relapse risk, Bone Marrow Transplantation 50: S40-S41.
- Jol-van der Zijde, E.; Jansen-Hoogendijk, A.; Hale, G.; Lankester, A.; Bredius, R. & Tol, M. van (2015), NK-cell recovery after allogeneic HSCT occurs in the presence of circulating Thymoglobulin (ATG) or Alemtuzumab, Bone Marrow Transplantation 50: S42-S43.
- Boelens, J.; Bredius, R.; Versluys, B.; Kollen, W.; Lindemans, C.A.; Lankester, A. & Bierings, M. (2015), Combining Clofarabine/Fludarabine with Exposure Targeted Busulfan for Pediatric Leukemia: An Effective, Low Toxic TBI-Free Conditioning Regimen, Biology of Blood and Marrow Transplantation 21(2): S93-S94.
- Jonkman-Berk, B.M.; Berg, J.M. van den; Berge, I.J.M. ten; Bredius, R.G.M.; Driessen, G.J.; Dalm, V.A.S.H.; Dissel, J.T. van; Deuren, M. van; Ellerbroek, P.M.; Flier, M. van der; Hagen, P.M. van; Montfrans, J.M. van; Rutgers, A.; Scholvinck, E.H.; Vries, E. de; Beem, R.T. van & Kuijpers, T.W. (2015), Primary immunodeficiencies in the Netherlands: National patient data demonstrate the increased risk of malignancy, Clinical Immunology 156(2): 154-162.
- Lalmohamed, A.; Bartelink, I.; Reij, L. van; Dvorak, C.C.; Savic, R.; Zwaveling, J.; Bredius, R.; Egberts, A.; Bierings, M.; Kletzel, M.; Shaw, P.; Nath, C.; Hempel, G.; Ansari, M.; Krajinovic, M.; Gungor, T.; Wynn, R.F.; Veys, P.; Cuvelier, G.; Chiesa, R.; Slatter, M.; Long-Boyle, J. & Boelens, J. (2015), Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study, Biology of Blood and Marrow Transplantation 21(2): S102-S103.
- Lugthart, G.; Oomen, M.A.; Zijde, C.M.J.V.D.; Ball, L.M.; Bresters, D.; Kollen, W.J.W.; Smiers, F.J.; Vermont, C.L.; Bredius, R.G.M.; Schilham, M.W.; Tol, M.J.D. van & Lankester, A.C. (2015), The Effect of Cidofovir on Adenovirus Plasma DNA Levels in Stem Cell Transplantation Recipients without T Cell Reconstitution, Biology of Blood and Marrow Transplantation 21(2): 293-299.
- Admiraal, R.; Kesteren, C. van; Jol-van der Zijde, C.M.; Lankester, A.; Bierings, M.; Tol, M. van; Knibbe, C.A.J.; Bredius, R. & Boelens, J.J. (2015), Thymoglobulin (R) Exposure Is Influencing CD4+Immune Reconstitution As a Predictor for Improved Overall Survival in Pediatric Haematopoietic Cell Transplantation: Towards Individualized Dosing, Biology of Blood and Marrow Transplantation 21(2): S91-S92.
- Brink, M.H. ten; Bredius, R.G.M.; Zwaveling, J.; Ackaert, O.; Hartigh, J. den; Smiers, F.J.; Guchelaar, H.J. & Lankester, A. (2014), Treosulfan-Based Conditioning in Pediatric Hematopoietic Stem Cell Transplantation: A Prospective Study on Pharmacokinetics and Early Clinical Outcomes, Blood 124(21).
- Pike-Overzet, K.; Baert, M.R.M.; Schambach, A.; Rothe, M.; Zhang, F.; Lankester, A.C.; Bredius, R.G.M.; Thrasher, A.J.; Gaspar, H.B. & Staal, F.J.T. (2014), Finding levels of RAG1 expression that will correct RAG1 Severe Combined Immunodeficiency, Human Gene Therapy 25(11): A41-A41.
- Wiekmeijer, A.; Pike-Overzet, K.; Brugman, M.H.; Wolvers-Tettero, I.L.M.; Lankester, A.C.; Bredius, R.G.M.; Dongen, J.J.M. van; Fibbe, W.E.; Langerak, A.W.; Burg, M. van der & Staal, F.J.T. (2014), Transplantation of human SCID stem cells in NSG mice gives new insights into human T-cell development and reveals where SCID mutations act, Human Gene Therapy 25(11): A41-A41.
- Pagter, P.J.; Bredius, R.G.; Tramper, J.; Kuijpers, T.W.; Burg, M. van der; Montfrans, J.M. van & Driessen, G.J. (2014), Overview of 15 Years Severe Combined Immunodeficiency in The Netherlands: Towards Neonatal Blood Spot Screening, Journal of Clinical Immunology 34: S442-S443.
- Bredius, R.G.M.; Zwan, A. van der; Zelm, M.C. van; Ostaijen-ten Dam, M.M. van; Jol-van der Zijde, C.M.; Tol, M.J.D. van & Lankester, A.C. (2014), Persistent Hypogammaglobulinemia Following Rituximab (ANTI-CD20) Treatment After Pediatric Allogeneic Stem Cell Transplantation, Journal of Clinical Immunology 34: S277-S278.
- Brink, M.H. ten; Zwaveling, J.; Swen, J.J.; Bredius, R.G.M.; Lankester, A.C. & Guchelaar, H.J. (2014), Personalized busulfan and treosulfan conditioning for pediatric stem cell transplantation: the role of pharmacogenetics and pharmacokinetics, Drug Discovery Today 19(10): 1572-1586.
- Vossen, J.M.; Guiot, H.F.L.; Lankester, A.C.; Vossen, A.C.T.M.; Bredius, R.G.M.; Wolterbeek, R.; Bakker, H.D.J. & Heidt, P.J. (2014), Complete Suppression of the Gut Microbiome Prevents Acute Graft- Versus-Host Disease following Allogeneic Bone Marrow Transplantation, PLoS ONE 9(9).
- Brink, M. ten; Ackaert, O.; Zwaveling, J.; Bredius, R.G.; Smiers, F.J.; Hartigh, J. den; Lankester, A.C. & Guchelaar, H. (2014), Pharmacokinetics of Treosulfan in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation, Therapeutic Drug Monitoring 36(4): 465-472.
- Gathmann, B.; Mahlaoui, N.; Gerard, L.; Oksenhendler, E.; Warnatz, K.; Schulze, I.; Kindle, G.; Kuijpers, T.W.; Beem, R.T. van; Guzman, D.; Workman, S.; Soler-Palacin, P.; Gracia, J. de; Witte, T.; Schmidt, R.E.; Litzman, J.; Hlavackova, E.; Thon, V.; Borte, M.; Borte, S.; Kumararatne, D.; Kumararatne, D.; Longhurst, H.; Helbert, M.; Szaflarska, A.; Sediva, A.; Belohradsky, B.H.; Jones, A.; Baumann, U.; Meyts, I.; Kutukculer, N.; Wagstrom, P.; Galal, N.M.; Roesler, J.; Farmaki, E.; Zinovieva, N.; Ciznar, P.; Papadopoulou-Alataki, E.; Bienemann, K.; Velbri, S.; Panahloo, Z.; Grimbacher, B.; CEREDIH; Dutch WID & European Soc Immunodeficiencies (2014), Clinical picture and treatment of 2212 patients with common variable immunodeficiency, Journal of Allergy and Clinical Immunology 134(1): 116-+.
- Pike-Overzet, K.; Baum, C.; Bredius, R.G.M.; Cavazzana, M.; Driessen, G.J.; Fibbe, W.E.; Gaspar, H.B.; Hoeben, R.C.; Lagresle-Peyrou, C.; Lankester, A.; Meij, P.; Schambach, A.; Thrasher, A.; Dongen, J.J.M. van; Zwaginga, J.J. & Staal, F.J.T. (2014), Successful RAG1-SCID gene therapy depends on the level of RAG1 expression.
- Ammann, S.; Elling, R.; Gyrd-Hansen, M.; Duckers, G.; Bredius, R.; Burns, S.O.; Edgar, J.D.M.; Worth, A.; Brandau, H.; Warnatz, K.; Stadt, U. zur; Hasselblatt, P.; Schwarz, K.; Ehl, S. & Speckmann, C. (2014), A new functional assay for the diagnosis of X-linked inhibitor of apoptosis (XIAP) deficiency, Clinical and Experimental Immunology 176(3): 394-400.
- Schatorje, E.J.H.; Gathmann, B.; Hout, R.W.N.M. van; Vries, E. de & PedPAD Consortium (2014), The PedPAD study: boys predominate in the hypogammaglobulinaemia registry of the ESID online database, Clinical and Experimental Immunology 176(3): 387-393.
- Lugthart, G.; Ostaijen-ten Dam, M.M. van; Jol-van der Zijde, C.M.; Holten, T.C. van; Kester, M.G.D.; Heemskerk, M.H.M.; Bredius, R.G.M.; Toll, M.J.D. van & Lankester, A.C. (2014), Early Cytomegalovirus Reactivation Leaves a Specific and Dynamic Imprint on the Reconstituting T Cell Compartment Long-Term after Hematopoietic Stem Cell Transplantation, Biology of Blood and Marrow Transplantation 20(5): 655-661.
- Vermont, C.L.; Jol-van der Zijde, E.C.M.; Hissink Muller, P.; Ball, L.M.; Bredius, R.G.M.; Vossen, A.C. & Lankester, A.C. (2014), Varicella zoster reactivation after hematopoietic stem cell transplant in children is strongly correlated with leukemia treatment and suppression of host T-lymphocyte immunity, Transplant Infectious Disease 16(2): 188-194.
- Brink, M. ten; Bavel, T. van; Swen, J.J.; Straaten, T. van der; Bredius, R.G.; Lankester, A.C.; Zwaveling, J. & Guchelaar, H. (2014), THE ROLE OF GENETIC VARIANTS GSTA1 AND CYP39A1 AND ONTOGENESIS ON BUSULFAN CLEARANCE IN PEDIATRIC PATIENTS UNDERGOING HEMATOPOIETIC SCT., Clinical Pharmacology and Therapeutics 95: S100-S100.
- Admiraal, R.; Kesteren, C. van; Boelens, J.J.; Bredius, R.G.M.; Tibboel, D. & Knibbe, C.A.J. (2014), Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling, Archives of Disease in Childhood 99(3): 267-272.
- Admiraal, R.; Jol-van der Zijde, C.M.; Kesteren, C. van; Tol, M. van; Knibbe, C.A.J.; Bredius, R. & Boelens, J.J. (2014), Exposure of Thymoglobulin Is Associated with Overall Survival in Children Receiving Allogeneic-Hematopoietic Cell Transplantation (HCT): Towards Individualized Dosing to Improve Survival, Biology of Blood and Marrow Transplantation 20(2): S76-S78.
- Hol, J.; Ruggeri, A.; Rocha, V.G.; Michel, G.; Ayas, M.; O'Brien, T.; Krivan, G.; Bordon, V.; Schots, R.; Rovelli, A.; Elorza, I.; Moraleda, J.; Shaw, P.J.; Renard, M.; Sykora, K.W.; Or, R.; Zuckerman, T.; Abecasis, M.; Bredius, R.; Yesilipek, M.A.; Diaz, M.A.; Genner, A.; Gluckman, E. & Boelens, J.J. (2014), Outcomes of Allogeneic Cord Blood Transplantation for Leukodystrophies; A Joint Study of Eurocord and "Inborn Errors WP-EBMT", Biology of Blood and Marrow Transplantation 20(2): S86-S87.
- Admiraal, R.; Kesteren, C. van; Jol-van Der Zijde, C.M.; Tol, M. van; Bartelink, I.; Bredius, R.; Boelens, J.J. & Knibbe, C.A.J. (2014), Population Pharmacokinetic Modeling of Thymoglobulin in Children Receiving Allogeneic-Hematopoietic Cell Transplantation (HCT): Towards Individualized Dosing to Improve Survival, Biology of Blood and Marrow Transplantation 20(2): S96-S98.
- Gungor, T.; Teira, P.; Slatter, M.; Stussi, G.; Stepensky, P.; Moshous, D.; Vermont, C.; Ahmad, I.; Shaw, P.J.; Cunha, J.M.T. da; Schlegel, P.G.; Hough, R.; Fasth, A.; Kentouche, K.; Gruhn, B.; Fernandes, J.F.; Lachance, S.; Bredius, R.; Resnick, I.B.; Belohradsky, B.H.; Gennery, A.; Fischer, A.; Gaspar, H.B.; Schanz, U.; Seger, R.; Rentsch, K.; Veys, P.; Haddad, E.; Albert, M.H.; Hassan, M. & Inborn Errors Working Party Europe (2014), Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study, Lancet 383(9915): 436-448.
- Iacono, N. lo; Pangrazio, A.; Abinun, M.; Bredius, R.; Zecca, M.; Blair, H.C.; Vezzoni, P.; Villa, A. & Sobacchi, C. (2013), RANKL Cytokine: From Pioneer of the Osteoimmunology Era to Cure for a Rare Disease.
- Brink, M.H. ten; Bavel, T. van; Swen, J.J.; Straaten, T. van der; Bredius, R.G.M.; Lankester, A.C.; Zwaveling, J. & Guchelaar, H.J. (2013), Effect of genetic variants GSTA1 and CYP39A1 and age on busulfan clearance in pediatric patients undergoing hematopoietic stem cell transplantation, Pharmacogenomics 14(14): 1683-1690.
- Savic, R.M.; Cowan, M.J.; Dvorak, C.C.; Pai, S.Y.; Pereira, L.; Bartelink, I.H.; Boelens, J.J.; Bredius, R.G.M.; Wynn, R.F.; Cuvelier, G.D.E.; Shaw, P.J.; Slatter, M.A. & Long-Boyle, J. (2013), Effect of Weight and Maturation on Busulfan Clearance in Infants and Small Children Undergoing Hematopoietic Cell Transplantation, Biology of Blood and Marrow Transplantation 19(11): 1608-1614.
- Lugthart, G.; Ostaijen-Ten Dam, M.M. van; Jol-van der Zijde, C.M.; Holten, T.C. van; Kester, M.G.D.; Heemskerk, M.H.M.; Bredius, R.G.M.; Tol, M.J.D. van & Lankester, A.C. (2013), Imprint Of Early CMV Reactivation On The Reconstituting T-Lymphocyte Compartment One and Two Year After Hematopoietic Stem Cell Transplantation, Blood 122(21).
- Lugthart, G.; Oomen, M.A.; Jol-van der Zijde, C.M.; Ball, L.M.; Bresters, D.; Kollen, W.J.W.; Smiers, F.J.; Vermont, C.L.; Bredius, R.G.M.; Schilham, M.W.; Tol, M.J.D. van & Lankester, A.C. (2013), The Effectiveness Of Cidofovir In Disseminated Adenovirus Infections After Pediatric HSCT Is Closely Related To Lymphocyte Reconstitution, Blood 122(21).
- Korthof, E.T.; Svahn, J.; Latour, R.P. de; Terranova, P.; Moins-Teisserenc, H.; Socie, G.; Soulier, J.; Kok, M.; Bredius, R.G.M.; Tol, M. van; Jol-van der Zijde, E.C.M.; Pistorio, A.; Corsolini, F.; Parodi, A.; Battaglia, F.; Pistoia, V.; Dufour, C. & Cappelli, E. (2013), Immunological profile of Fanconi anemia: A multicentric retrospective analysis of 61 patients, American Journal of Hematology 88(6): 472-476.
- Pike-Overzet, K.; Wiekmeijer, A.S.; Baert, M.R.M.; Lagresle-Peyrou, C.; Schambach, A.; Zhang, F.; Hoeben, R.C.; Hacein-Bey-Abina, S.; Lankester, A.C.; Bredius, R.G.M.; Driessen, G.J.A.; Thrasher, A.J.; Baum, C.; Cavazzana-Calvo, M.; Dongen, J.J.M. van & Staal, F.J.T. (2013), Self-Inactivating Lentiviral Vectors for Correction of Rag1 Severe Combined Immunodeficiency, Molecular Therapy 21: S120-S121.
- Jol-van der Zijde, C.M.; Willemsen, L.; Putter, H.; Lankester, A.C.; Bredius, R.G.M. & Tol, M.J.D. van (2013), Impact of serotherapy on the outcome after stem cell transplantation in children: ATG versus Campath-1H, Bone Marrow Transplantation 48: S54-S54.
- Vlug, R.; Bertels, R.; Lankester, A.; Bredius, R.; Bresters, D. & Smiers, F. (2013), Pulmonary hypertension following paediatric allogeneic stem cell transplantation: improved outcome after treatment with sildenafil, Bone Marrow Transplantation 48: S288-S288.
- Prete, F.; Catucci, M.; Labrada, M.; Gobessi, S.; Castiello, M.C.; Bonomi, E.; Aiuti, A.; Vermi, W.; Cancrini, C.; Metin, A.; Hambleton, S.; Bredius, R.; Notarangelo, L.D.; Burg, M. van der; Kalinke, U.; Villa, A. & Benvenuti, F. (2013), Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells.
- Beek, M.T. van der; Vermont, C.L.; Bredius, R.G.M.; Marijt, E.W.A.; Blij-de Brouwer, C.S. van der; Kroes, A.C.M.; Claas, E.C.J. & Vossen, A.C.T.M. (2013), Persistence and Antiviral Resistance of Varicella Zoster Virus in Hematological Patients.
- Scaramuzza, S.; Biasco, L.; Ripamonti, A.; Castiello, M.C.; Loperfido, M.; Draghici, E.; Hernandez, R.J.; Benedicenti, F.; Radrizzani, M.; Salomoni, M.; Ranzani, M.; Bartholomae, C.C.; Vicenzi, E.; Finocchi, A.; Bredius, R.; Bosticardo, M.; Schmidt, M.; Kalle, C. von; Montini, E.; Biffi, A.; Roncarolo, M.G.; Naldini, L.; Villa, A. & Aiuti, A. (2013), Preclinical Safety and Efficacy of Human CD34(+) Cells Transduced With Lentiviral Vector for the Treatment of Wiskott-Aldrich Syndrome, Molecular Therapy 21(1): 175-184.
- Bartelink, I.H.; Boelens, J.J.; Bredius, R.G.M.; Egberts, A.C.G.; Wang, C.G.; Bierings, M.B.; Shaw, P.J.; Nath, C.E.; Hempe, G.; Zwaveling, J.; Danhof, M. & Knibbe, C.A.J. (2012), Body Weight-Dependent Pharmacokinetics of Busulfan in Paediatric Haematopoietic Stem Cell Transplantation Patients Towards Individualized Dosing, Clinical Pharmacokinetics 51(5): 331-345.
- Pike-Overzet, K.; Rodijk, M.; Ng, Y.Y.; Baert, M.R.M.; Lagresle-Peyrou, C.; Schambach, A.; Zhang, F.; Hoeben, R.C.; Hacein-Bey-Abina, S.; Lankester, A.C.; Bredius, R.G.M.; Driessen, G.J.A.; Thrasher, A.J.; Baum, C.; Cavazzana-Calvo, M.; Dongen, J.J.M. van & Staal, F.J.T. (2012), Self-Inactivating Lentiviral Vectors for Correction of Rag1 Severe Combined Immunodeficiency, Human Gene Therapy 23(10): A42-A42.
- Hassan, A.; Booth, C.; Brightwell, A.; Allwood, Z.; Veys, P.; Rao, K.; Honig, M.; Friedrich, W.; Gennery, A.; Slatter, M.; Bredius, R.; Finocchi, A.; Cancrini, C.; Aiuti, A.; Porta, F.; Lanfranchi, A.; Ridella, M.; Steward, C.; Filipovich, A.; Marsh, R.; Bordon, V.; Al-Muhsen, S.; Al-Mousa, H.; Alsum, Z.; Al-Dhekri, H.; Ghonaium, A. al; Speckmann, C.; Fischer, A.; Mahlaoui, N.; Nichols, K.E.; Grunebaum, E.; Zahrani, D. al; Roifman, C.M.; Boelens, J.; Davies, E.G.; Cavazzana-Calvo, M.; Notarangelo, L.; Gaspar, H.B.; European Grp Blood Marrow Transpla & European Soc Immunodeficiency (2012), Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency, Blood 120(17): 3615-3624.
- Jol-van der Zijde, C.M.; Bredius, R.G.M.; Jansen-Hoogendijk, A.M.; Smiers, F.J.; Lankester, A.C. & Tol, M.J.D. van (2012), Antibodies to anti-thymocyte globulin in aplastic anemia patients have a negative impact on hematopoietic SCT, Bone Marrow Transplantation 47(9): 1256-1258.
- Aydin, S.; Freeman, A.F.; Sanal, O.; Al-Mousa, H.; Matthes-Martin, S.; Cuellar-Rodriguez, J.; Hickstein, D.D.; Tavil, B.; Azik, F.M.; Bittner, T.C.; Bredius, R.G.; Ayvaz, D.; Kuskonmaz, B.; Honig, M.; Schulz, A.; Picard, C.; Barlogis, V.; Gennery, A.; Ifversen, M.; Montfrans, J.M. van; Kuijpers, T.W.; Duckers, G.; Al-Herz, W.; Pai, S.Y.; Geha, R.S.; Notheis, G.; Schwarze, C.P.; Schuster, F.; Gathmann, B.; Grimbacher, B.; Gaspar, B.; Belohradsky, B.H.; Ochs, H.; Renner, E.; Chatila, T.; Engelhardt, K.R. & Albert, M.H. (2012), MANAGEMENT OF DOCK8 DEFICIENCY BY HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT), Journal of Clinical Immunology 32: 127-128.
- Pike-Overzet, K.; Rodijk, M.; Ng, Y.Y.; Baert, M.; Lagresle-Peyrou, C.; Schambach, A.; Zhang, F.; Hoeben, R.; Hacein-Bey-Abina, S.; Lankester, A.; Bredius, R.; Driessen, G.; Thrasher, A.; Baum, C.; Cavazzana-Calvo, M.; Dongen, J. van & Staal, F. (2012), SELF-INACTIVATING LENTIVIRAL VECTORS FOR CORRECTION OF RAG1 SEVERE COMBINED IMMUNODEFICIENCY, Experimental Hematology 40(8): S46-S47.
- Jol-van der Zijde, C.M.; Bredius, R.G.M.; Jansen-Hoogendijk, A.M.; Raaijmakers, S.; Egeler, R.M.; Lankester, A.C. & Tol, M.J.D. van (2012), IgG antibodies to ATG early after pediatric hematopoietic SCT increase the risk of acute GVHD, Bone Marrow Transplantation 47(3): 360-368.
- Fernandes, J.F.; Rocha, V.; Labopin, M.; Neven, B.; Moshous, D.; Gennery, A.R.; Friedrich, W.; Porta, F.; Heredia, C.D. de; Wall, D.; Bertrand, Y.; Veys, P.; Slatter, M.; Schulz, A.; Chan, K.W.; Grimley, M.; Ayas, M.; Gungor, T.; Ebell, W.; Bonfim, C.; Kalwak, K.; Taupin, P.; Blanche, S.; Gaspar, H.B.; Landais, P.; Fischer, A.; Gluckman, E.; Cavazzana-Calvo, M. & Eurocord Inborn Errors Working (2012), Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?, Blood 119(12): 2949-2955.
- Walraven, S.M. van; Ball, L.M.; Koopman, H.M.; Switzer, G.E.; Ropes-de Jong, C.M.H.; Jong, A. de; Bredius, R.G.M. & Egeler, R.M. (2012), Managing a dual roleuexperiences and coping strategies of parents donating haploidentical G-CSF mobilized peripheral blood stem cells to their children, Psycho-Oncology 21(2): 168-175.
- Albert, M.H.; Aydin, S.; Matthes-Martin, S.; Hoenig, M.; Schulz, A.; Steinmann, S.; Barlogis, V.; Gennery, A.; Ifversen, M.; Montfrans, J. van; Kuijpers, T.; Bredius, R.; Vermont, C.; Bittner, T.; Notheis, G.; Belohradsky, B.H.; Sawalle-Belohradsky, J.; Heinz, V.; Gathmann, B.; Ochs, H.D.; Renner, E.D. & Gaspar, B. (2012), MULTI-INSTITUTIONAL EXPERIENCE OF HSCT FOR DOCK8 DEFICIENCY, Biology of Blood and Marrow Transplantation 18(2): S228-S228.
- Kuijpers, T.W.; Baars, P.A.; Kerk, D.J. aan de; Jansen, M.H.; Derks, I.A.M.; Bredius, R.G.M.; Sanders, E.A.M.; Burg, M. van der; Alders, M. & Lier, R.A.W. van (2011), A novel mutation in CD132 causes X-CID with defective T-cell activation and impaired humoral reactivity.
- Bartelink, I.H.; Boelens, J.J.; Bredius, R.G.M.; Egberts, A.C.G.; Bierings, M.; Shaw, P.; Hempel, G.; Zwaveling, J.; Danhof, M. & Knibbe, C.A.J. (2011), Modeling of the age-related pharmacokinetics in children. A date-driven analysis of Busulfan prior to haemopoietic stem cell transplantation, British Journal of Clinical Pharmacology 72(5): 843-844.
- Terranova, P.; Cappelli, E.; Latour, R.P. de; Svahn, J.; Soulier, J.; Bredius, R.; Kok, M.; Zijde, E.J. van der; Tol, M. van; Socie, G.; Moins, H.; Dufour, C. & Korthof, E.T. (2011), Immunological Prophile of FA. A Multicentric retrospective Analysis of 61 Patients, Blood 118(21): 593-593.
- Pike-Overzet, K.; Rodijk, M.; Ng, Y.Y.; Baert, M.R.M.; Lagresle-Peyrou, C.; Schambach, A.; Zhang, F.; Hoeben, R.C.; Hacein-Bey-Abina, S.; Lankester, A.C.; Bredius, R.G.M.; Driessen, G.J.A.; Thrasher, A.J.; Baum, C.; Cavazzana-Calvo, M.; Dongen, J.J.M. van & Staal, F.J.T. (2011), Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer, Leukemia 25(9): 1471-1483.
- Hendriks, R.W.; Bredius, R.G.M.; Pike-Overzet, K. & Staal, F.J.T. (2011), Biology and novel treatment options for XLA, the most common monogenetic immunodeficiency in man, Expert Opinion on Therapeutic Targets 15(8): 1003-1021.
- Bruele, T. van den; Mourad-Baars, P.E.C.; Claas, E.C.J.; Plas, R.N. van der; Kuijper, E.J. & Bredius, R.G.M. (2010), Campylobacter jejuni bacteremia and Helicobacter pylori in a patient with X-linked agammaglobulinemia, European Journal of Clinical Microbiology and Infectious Diseases 29(11): 1315-1319.
- Gennery, A.R.; Slatter, M.A.; Grandin, L.; Taupin, P.; Cant, A.J.; Veys, P.; Amrolia, P.J.; Gaspar, H.B.; Davies, E.G.; Friedrich, W.; Hoenig, M.; Notarangelo, L.D.; Mazzolari, E.; Porta, F.; Bredius, R.G.M.; Lankester, A.C.; Wulffraat, N.M.; Seger, R.; Gungor, T.; Fasth, A.; Sedlacek, P.; Neven, B.; Blanche, S.; Fischer, A.; Cavazzana-Calvo, M.; Landais, P.; European Group For Blood & European Society For (2010), Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: Entering a new century, do we do better?, Journal of Allergy and Clinical Immunology 126(3): 602U342.
- Bordon, V.; Gennery, A.R.; Slatter, M.A.; Vandecruys, E.; Laureys, G.; Veys, P.; Waseem, Q.; Friedrich, W.; Wulfraat, N.M.; Scherer, F.; Cant, A.J.; Fischer, A.; Cavazzana-Calvo, M.; Bredius, R.G.M.; Notarangelo, L.D.; Mazzolari, E.; Neven, B. & Tayfun, G. (2010), Clinical and immunologic outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantation, Blood 116(1): 27-35.
- Smiers, F.J.; Vijver, E. van de; Delsing, B.J.P.; Lankester, A.C.; Ball, L.M.; Rings, E.H.H.M.; Rheenen, P.F. van & Bredius, R.G.M. (2010), Delayed immune recovery following sequential orthotopic liver transplantation and haploidentical stem cell transplantation in erythropoietic protoporphyria.
- Chaudhry, S.H.; Chaudhry, S.; Jansen-Hoogendijk, A.M.; Zijde, C.M.J. van der; Tol, M.J.D. van; Roos, A. & Bredius, R.G.M. (2010), Mannose-binding lectin levels and infections in children after allogeneic hematopoietic SCT, Bone Marrow Transplantation 45(2): 289-293.
- Faaij, C.M.; Annels, N.E.; Ruigrok, G.; Burg, M. van der; Ball, L.M.; Bredius, R.G.; Tol, M.J. van & Lankester, A.C. (2010), Decrease of Skin Infiltrating and Circulating CCR10+T Cells Coincides with Clinical Improvement after Topical Tacrolimus in Omenn Syndrome, Journal of Investigative Dermatology 130(1): 308-311.
- Vossen, J.M.; Donker, A.E.; Heemskerk, M.B.A.; Lie, J.L.W.T.J.; Weel-Sipman, M.H. van; Bredius, R.G.M.; Bakker, J.D.J.; Egeler, R.M. & Oudshoorn, M. (2010), Unrelated donor marrow transplantation in children: transplant policy and outcome in Leiden Paediatrics SCT-Centre, Bone Marrow Transplantation 45(1): 87-95.
- Vossen, J.M.; Donker, A.E.; Heemskerk, M.B.A.; Lie, J.L.W.T.J.; Weel-Sipman, M.H. van; Bredius, R.G.M.; Bakker, J.D.J.; Egeler, R.M. & Oudshoorn, M. (2010), Unrelated donor marrow transplantation in children: transplant policy and outcome in Leiden Paediatrics SCT-Centre., Bone Marrow Transplantation 45(1): 87-95.
- Djuardi Y, Wibowo H, Supali T, Ariawan I, Bredius RGM, Yazdanbakhsh M, Rodrigues LC & Sartono E (2009), Determinants of the Relationship between Cytokine Production in Pregnant Women and Their Infants, PLoS ONE 4(11).
- ten Bosch JEV, Kollen WJW, Ball LM, Brinkman DMC, Vossen ACTM, Lankester AC, Egeler RM & Bredius RGM (2009), Atypical Varicella Zoster Infection Associated With Hemophagocytic Lymphohistiocytosis, Pediatric Blood and Cancer 53(2): 226-228.
- Vrijmoet-Wiersma CMJ, Kolk AM, Grootenhuis MA, Spek EM, van Klink JMM, Egeler RM, Bredius RGM & Koopman HM (2009), Child and parental adaptation to pediatric stem cell transplantation, Supportive Care in Cancer 17(6): 707-714.
- de Vries JJC, Bredius RGM, van Rheenen PF, Smiers FJW, Scholvinck EH, Vossen ACTM, Claas ECJ & Niesters HGM (2009), Human Bocavirus in an Immunocompromised Child Presenting with Severe Diarrhea, Journal of Clinical Microbiology 47(4): 1241-1243.
- Locci M, Draghici E, Marangoni F, Bosticardo M, Catucci M, Aiuti A, Cancrini C, Marodi L, Espanol T & Bredius RGM (2009), The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function, Journal of Experimental Medicine 206(4): 735-742.
- Bartelink IH, Bredius RGM, Belitser SV, Suttorp MM, Bierings M, Knibbe CAJ, Egeler M, Lankester AC, Egberts ACG & Zwaveling J (2009), Association between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan before Hematologic Stem Cell Transplantation, Biology of Blood and Marrow Transplantation 15(2): 231-241.
- de Vries ACH, Bredius RGM, Lankester AC, Bierings M, Trebo M, Sedlacek P, Niemeyer CM, Zecca M, Locatelli F & van den Heuvel-Eibrink MM (2009), HLA-identical umbilical cord blood transplantation from a sibling donor in juvenile myelomonocytic leukemia, Haematologica 94(2): 302-304.
- Zwaveling J, Press RR, Bredius RGM, van der Straaten TRJHM, den Hartigh J, Bartelink IH, Boelens JJ & Guchelaar HJ (2008), Glutathione S-transferase polymorphisms are not associated with population pharmacokinetic parameters of busulfan in pediatric patients, Therapeutic Drug Monitoring 30(4).
- Ball L, Bredius R, Lankester A, Schweizer J, van den Heuvel-Eibrink M, Escher H, Fibbe W & Egeler M (2008), Third party mesenchymal stromal cell infusions fail to induce tissue repair despite successful control of severe grade IV acute graft-versus-host disease in a child with juvenile myelo-monocytic leukemia, Leukemia 22(6).
- Bresters D, Van Gils ICM, Dekker FW, Lankester AC, Bredius RGM & Schweizer JJ (2008), Abnormal liver enzymes two years after haematopoietic stem cell transplantation in children: prevalence and risk factors, Bone Marrow Transplantation 41(1).
- Bartelink IH, Bredius RGM, Ververs TT, Raphael MF, van Kesteren C, Bierings M, Rademaker CMA, den Hartigh J, Uiterwaal CSPM, Zwaveling J & Boelens JJ (2008), Once-daily intravenous busulfan with therapeutic drug monitoring compared to conventional oral busulfan improves survival and engraftment in children undergoing allogeneic stem cell transplantation, Biology of Blood and Marrow Transplantation 14(1).
- Ozsahin H, Cavazzana-Calvo M, Notarangelo LD, Schulz A, Thrasher AJ, Mazzolari E, Slatter MA, Le Deist F, Blanche S, Veys P, Fasth A, Bredius R, Sedlacek P, Wulffraat N, Ortega J, Heilmann C, O'Meara A, Wachowiak J, Kalwak K, Matthes-Martin S, Gungor T, Ikinciogullari A, Landais P, Cant AJ, Friedrich W & Fischer A (2008), Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation, Blood 111(1).
- Gennery AR, Slatter MA, Bredius RG, Hagleitner MM, Weemaes C, Cant AJ & Lankester AC (2007), Hematopoietic stem cell transplantation corrects the immunologic abnormalities associated with immunodeficiency-centromeric instability-facial dysmorphism syndrome, Pediatrics 120(5).
- Sobacchi C, Frattini A, Guerrini MM, Abinun M, Pangrazio A, Susani L, Bredius R, Mancini G, Cant A, Bishop N, Grabowski P, Del Fattore A, Messina C, Errigo G, Coxon FP, Scott DI, Teti A, Rogers MJ, Vezzoni P, Villa A & Helfrich MH (2007), Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL, Nature Genetics 39(8).
- Bredius RGM, Laan LAEM, Lankester AC, Poorthuis BJHM, van Tol MJD, Egeler RM & Arts WFM (2007), Early marrow transplantation in a pre-symptomatic neonate with late infantile metachromatic leukodystrophy does not halt disease progression, Bone Marrow Transplantation 39(5).
- Zwaveling J, den Hartigh J, Lankester AC, Guchelaar HJ, Egeler RM & Bredius RGM (2006), Once-daily intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics and early clinical outcomeos, Anti-Cancer Drugs 17(9).
- Borghans JA, Bredius RG, Hazenberg MD, Roelofs H, Zijde ECJVD, Heidt J, Otto SA, Kuijpers TW, Fibbe WE, Vossen JM, Miedema F & van Tol MJ (2006), Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency, Blood 108(2).
- Annels NE, Kalpoe JS, Bredius RGM, Claas EC, Kroes ACM, Hislop AD, van Baarle D, Egeler RM, van Tol MJD & Lankester AC (2006), Management of Epstein-Barr virus (EBV) reactivation after allogeneic stem cell transplantation by simultaneous analysis of EBV DNA load and EBV-specific T cell reconstitution, Clinical Infectious Diseases 42(12).
- Nicholls BM, Bredius RGM, Hamdy NAT, Gerritsen EJA, Lankester AC, Hogendoorn PCW, Nesbitt SA, Horton MA & Flanagan AM (2005), Limited rescue of osteoclast-poor osteopetrosis after successful engraftment by cord blood from an unrelated donor, Journal of Bone and Mineral Research 20(12).
- Kist-van Holthe JE, Bresters D, Ahmed-Ousenkova YM, Goedvolk CA, Abbink FCH, Wolterbeek R, Bredius RGM, Pauwels EKJ & van der Heijden AJ (2005), Long-term renal function after hemopoietic stem cell transplantation in children, Bone Marrow Transplantation 36(7).
- Korthof ET, Snijder PP, de Graaff AA, Lankester AC, Bredius RGM, Ball LM, Lie JWLT, Vossen JM & Egeler RM (2005), Successful treatment of JMML with related bone marrow transplantation after reduced-intensity conditioning - Response, Bone Marrow Transplantation 36(5).
- Templeton KE, Bredius RGM, Claas ECJ, Kroes ACM & Walther FJ (2005), Parainfluenza virus 4 detection in infants, European Journal of Pediatrics 164(8).
- Lankester AC, Visser LFA, Hartwig NG, Bredius RGM, Gaspar HB, van der Burg M, van Tol MJD, Gross TG & Egeler RM (2005), Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature, Bone Marrow Transplantation 36(2).
- Heemskerk MBA, van Walraven SM, Cornelissen JJ, Barge RMY, Bredius RGM, Egeler RM, Lie JLWT, Revesz T, Sintnicolaas K, Wulffraat NM, Donker AE, Hoogerbrugge PM, van Rood JJ, Claas FHJ & Oudshoorn M (2005), How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more!, Bone Marrow Transplantation 35(7).
- Korthof ET, Snijder PP, de Graaff AA, Lankester AC, Bredius RGM, Ball LM, Lie JLWT, Vossen JM & Egeler RM (2005), Allogeneic bone marrow transplantation for juvenile myelomonocytic leukemia: a single center experience of 23 patients, Bone Marrow Transplantation 35(5).
- Ball LM, Lankester AC, Bredius RGM, Fibbe WE, van Tol MJD & Egeler RM (2005), Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation, Bone Marrow Transplantation 35.
- van den Heuvel-Eibrink MM, Bredius RGM, Winkel MLT, Tamminga R, de Kraker J, Schouten-van Meeteren AYN, Bruin M & Korthof ET (2005), Childhood paroxysmal nocturnal haemoglobinuria (PNH), a report of 11 cases in the Netherlands, British Journal of Haematology 128(4).
- Zwaveling J, Bredius RGM, Cremers SCLM, Ball LM, Lankester AC, Teepe-Twiss IM, Egeler RM, den Hartigh J & Vossen JM (2005), Intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics in association with early clinical outcome and toxicity, Bone Marrow Transplantation 35(1).
- Kuijpers TW, Nannenberg E, Alders M, Bredius R & Hennekam RCM (2004), Congenital aplastic anemia caused by mutations in the SBDS gene: A rare presentation of Shwachman-Diamond syndrome, Pediatrics 114(3).
- Janssen R, van Wengen A, Hoeve MA, ten Dam M, van der Burg M, van Dongen J, van de Vosse E, van Tol M, Bredius R, Ottenhoff TH, Weemaes C, van Dissel JT & Lankester A (2004), The same I kappa KB alpha mutation in two related individuals leads to completely different clinical syndromes, Journal of Experimental Medicine 200(5).
- Stranska R, van Loon AM, Polman M, Beersma MFC, Bredius RGM, Lankester AC, Meijer E & Schuurman R (2004), Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients, Antiviral Therapy 9(4).
- ten Cate R, Nibbering PH & Bredius RGM (2004), Therapy-refractory systemic juvenile idiopathic arthritis successfully treated with statins, Rheumatology 43(7).
- Bredius RGM, Templeton KE, Scheltinga SA, Claas ECJ, Kroes ACM & Vossen JM (2004), Prospective study of respiratory viral infections in pediatric hemopoietic stem cell transplantation patients, Pediatric Infectious Disease Journal 23(6).
- Lankester AC, Heemskerk B, Claas ECJ, Schilham MW, Beersma MFC, Bredius RGM, van Tol MJD & Kroes ACM (2004), Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection, Clinical Infectious Diseases 38(11).
- Bredius RGM, Ouachee M, van Brempt R, Bokenkamp R, Lankester AC, Dolman KM, Maarten Egeler R & Fischer A (2004), Pulmonary hypertension in two severe combined immunodeficiency disease patients posthaematopoietic stem cell transplantation, British Journal of Haematology 125(3).
- Templeton KE, Bredius RGM, Scheltinga SA, Claas ECJ, Vossen JM & Kroes ACM (2004), Parainfluenza virus 3 infection pre- and post-haematopoietic stem cell transplantation: re-infection or persistence?, Journal of Clinical Virology 29(4).
- ten Cate R, Smiers FJ, Bredius RGM, Lankester AC, van Suijlekom-Smit LWA, Huizinga TW & Egeler RM (2004), Anti-CD20 monoclonal antibody (rituximab) for refractory autoimmune thrombocytopenia in a girl with systemic lupus erythematosus, Rheumatology 43(2).
- Stranska R, van Loon AM, Bredius RGM, Polman M, Nienhuis E, Beersma MFC, Lankester AC & Schuurman R (2004), Sequential switching of DNA polymerase and thymidine kinase-mediated HSV-1 drug resistance in an immunocompromised child, Antiviral Therapy 9(1).
- Gennery AR, Khawaja K, Veys P, Bredius RGM, Notarangelo LD, Mazzolari E, Fischer A, Landais P, Cavazzana-Calvo M, Friedrich W, Fasth A, Wulffraat NM, Matthes-Martin S, Bensoussan D, Bordigoni P, Lange A, Pagliuca A, Andolina M, Cant AJ & Davies EG (2004), Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002, Blood 103(3).
- Ball LM, Lankester AC, Giordano PC, van Weel MH, Harteveld CL, Bredius RGM, Smiers FJ, Egeler RM & Vossen JMJJ (2003), Paediatric allogeneic bone marrow transplantation for homozygous beta-thalassaemia, the Dutch experience, Bone Marrow Transplantation 31(12).
- Hiltermann TJN, Bredius RGM, Gesink-van der Veer BJ, Corrin B, Rabe KF & Brahim JJ (2003), Bilateral cavitary pulmonary consolidations in a patient undergoing allogeneic bone marrow transplantation for acute leukemia, Chest 123(3).
- Antoine C, Muller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J, Fasth A, Heilmann C, Wulffraat N, Seger R, Blanche S, Friedrich W, Abinun M, Davies G, Bredius R, Schulz A, Landais P & Fischer A (2003), Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99, Lancet 361(9357).
- Kist-van Holthe JE, Goedvolk CA, Brand R, van Weel MH, Bredius RGM, van Oostayen JA, Vossen JMJJ & van der Heijden BJ (2002), Prospective study of renal insufficiency after bone marrow transplantation, Pediatric Nephrology 17(12).
- Cremers S, Schoemaker R, Bredius R, den Hartigh J, Ball L, Twiss I, Vermeij P & Vossen J (2002), Pharmacokinetics of intravenous busulfan in children prior to stem cell transplantation, British Journal of Clinical Pharmacology 53(4).
- Donker AE, van Merkesteyn JPR, Bredius RGM & van Weel-Sipman MH (2002), Value of panoramic radiographs in paediatric pre-bone marrow transplantation oral evaluation, International Journal of Oral and Maxillofacial Surgery 31(2).
- Laan LAEM, Bredius RGM, de Coo IFM, Bakker D & Egeler RM (2000), Childhood-onset cerebral X-linked adrenoleukodystrophy, Lancet 356(9241).
- Fijen CAP, Bredius RGM, Kuijper EJ, Out TA, De Haas M, De Wit APM, Daha MR & De Winkel JGJ (2000), The role of Fc gamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals.